Search

Your search keyword '"Zuberbier T."' showing total 1,976 results

Search Constraints

Start Over You searched for: Author "Zuberbier T." Remove constraint Author: "Zuberbier T."
1,976 results on '"Zuberbier T."'

Search Results

1. Identification by cluster analysis of patients with asthma and nasal symptoms using the MASK-air® mHealth app

2. Adherence to inhaled corticosteroids and long-acting β2-agonists in asthma: A MASK-air study

3. Quality of life measurement in urticaria: Position statement of the European Academy of Dermatology and Venereology Task Forces on Quality of Life and Patient‐Oriented Outcomes and Urticaria and Angioedema

4. Erratum to: Building bridges for innovation in ageing: Synergies between action groups of the EIP on AHA

6. Adressen

7. Allergic Rhinitis and its Impact on Asthma (ARIA) Phase 4 (2018): Change management in allergic rhinitis and asthma multimorbidity using mobile technology

8. Allergologische Diagnostik von Überempfindlichkeitsreaktionen auf Arzneimittel

9. From MASK-air® and SILAM to CATALYSE (Climate Action to Advance HeaLthY Societies in Europe)

10. Urtikaria und Angioödem

11. Rhinitis associated with asthma is distinct from rhinitis alone: The ARIA‐MeDALL hypothesis

12. Rhinitis associated with asthma is distinct from rhinitis alone:The ARIA-MeDALL hypothesis

13. Rhinitis associated with asthma is distinct from rhinitis alone: The ARIA-MeDALL hypothesis

14. Manifesto on small airway involvement and management in asthma and chronic obstructive pulmonary disease: an Interasma (Global Asthma Association - GAA) and World Allergy Organization (WAO) document endorsed by Allergic Rhinitis and its Impact on Asthma (ARIA) and Global Allergy and Asthma European Network (GA2LEN)

15. S3-Leitlinie: Klassifikation, Diagnostik und Therapie der Urtikaria

16. The ARIA-MeDALL hypothesis

17. Building bridges for innovation in ageing: Synergies between action groups of the EIP on AHA

18. Positioning the principles of precision medicine in care pathways for allergic rhinitis and chronic rhinosinusitis – A EUFOREA‐ARIA‐EPOS‐AIRWAYS ICP statement

20. Barriers of use of patient-reported outcome measures (PROMs) in asthma and rhinitis care: preliminary insights from the multinational ‘PROMUSE’ study

21. Physicians' preferences in the use of PROMs during asthma and allergic rhinitis clinical approach

22. Comprehensive Approach: Current Status on Patient Education in Atopic Dermatitis and Other Allergic Diseases

25. The Allergic Rhinitis and its Impact on Asthma (ARIA) score of allergic rhinitis using mobile technology correlates with quality of life: The MASK study

26. Transfer of innovation on allergic rhinitis and asthma multimorbidity in the elderly (MACVIA‐ARIA) ‐ EIP on AHA Twinning Reference Site (GARD research demonstration project)

29. Langzeiteffekte bei gezielter Mikronährstoff-Supplementierung mit der holo-BLG-Lutschtablette bei Patienten mit Hausstaubmilben-induzierter allergischer Rhinokonjunktivitis

30. Gelebte Interdisziplinarität: das Comprehensive Allergy Center der Charité (CACC) – Versorgung allergischer Patient/-innen im Kindes-, Jugend- und Erwachsenenalter

31. Correlation between work impairment, scores of rhinitis severity and asthma using the MASK-air ® App

32. Is diet partly responsible for differences in COVID-19 death rates between and within countries?

33. Identification by cluster analysis of patients with asthma and nasal symptoms using the MASK-air® mHealth app.

34. Experience-based advice on stepping up and stepping down the therapeutic management of chronic spontaneous urticaria: where is the guidance?

35. Work productivity in rhinitis using cell phones: The MASK pilot study

38. Anwendung von Biologika bei allergischen und Typ-2- entzündlichen Erkrankungen in der aktuellen COVID-19-Pandemie – ein Positionspapier von AeDA, DGAKI, GPA, ÖGAI, LGAI, ÖGP, ARIA und EAACI

39. Development and validation of combined symptom-medication scores for allergic rhinitis*

40. Allergen immunotherapy in MASK-air users in real-life: Results of a Bayesian mixed-effects model

41. A European survey of management approaches in chronic urticaria in children: EAACI pediatric urticaria taskforce

42. The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria

43. The SCF/KIT axis in human mast cells: Capicua acts as potent KIT repressor and ERK predominates PI3K

44. Behavioural patterns in allergic rhinitis medication in Europe: A study using MASK-air® real-world data

45. Causes of Urticaria

46. Cholinergic Urticaria

47. Urticaria Therapy

48. Diagnosis of Urticaria

50. ARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle

Catalog

Books, media, physical & digital resources